BrightGene Bio-Medical Technology Co., Ltd.

¥30.65As of Sun 8 Nov 2026, 12:00 UTC
SSE:688166Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 1.72%
Div yield 0.05%
ROE 3.49%
Biotechnology
Beta (5Y) 0.35
PE TTM 127.3
TSR TTM (46.58%)
Mkt cap ¥13.34B
ROIC 2.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥30
(2.71%)
(61.86%)
Hold 3|5|10|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.40
0.38
0.42
0.44
33.97%
19.30%
18.10%
17.74%
Revenue¥B
0.961
1.016
1.059
1.102
14.68%
20.91%
19.79%
21.11%
Peers (US$2.000B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
9.970
1.151
1.086
EBIT/Intx
1.088
0.112
0.108
Own earn%
(364.17)
(17.79)
(35.75)
Sh yield%
38.12
35.41
39.13
Owners
Insiders/Inst%
11.46
82.60
Short interest%
4.70
SBC / revenue%
2.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
18–21
$1 testx
—
Incr. ROIC%
2